RAPT Therapeutics Inc. (RAPT) Stock Price

8.00 ▼ -0.43 (-5.10%)
Open: 8.46 Vol: 71.2K Day's range: 7.966 - 8.46 Jun 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
RAPT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 8.09▼ 8.11▼ 8.09▼ 8.79▼ 8.31▼
MA10 8.11▼ 8.13▼ 8.23▼ 8.23▼ 7.89▲
MA20 8.12▼ 8.31▼ 8.75▼ 8.42▼ 8.26▼
MA50 8.14▼ 8.77▼ 8.23▼ 7.59▲ 11.64▼
MA100 8.46▼ 8.12▼ 8.41▼ 8.38▼ 59.33▼
MA200 8.55▼ 8.47▼ 8.12▼ 10.43▼ 123.79▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ -0.012▼ -0.134▼ -0.011▼ 0.732▲
RSI 39.937▼ 34.876▼ 38.508▼ 48.618▼ 44.142▼
STOCH 21.587     27.661     10.406▼ 58.347     54.256    
WILL %R -100.000▼ -90.196▼ -97.101▼ -64.103     -48.043    
CCI -171.492▼ -69.079     -71.017     -28.620     31.970    
Latest Filters Detected On RAPT
RSI $RAPT RSI(14) Crossed Below 50 Set Alert
▼ MACD $RAPT MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $RAPT Price Crossed Below MA(26) Set Alert
MA $RAPT Price Crossed Below MA(7) Set Alert
CDL $RAPT Marubozu Candlestick Pattern Detected Set Alert
RAPT Therapeutics Inc. News
RAPT Therapeutics Appoints Scott Braunstein, M.D. and Ashley Dombkowski, Ph.D. to Board of Directors - Nasdaq
Monday, June 23, 2025 05:13 AM
RAPT will have opportunities to also develop RPT904 in CSU and potentially other allergic diseases, and I am excited to help build this company.” Scott Braunstein, M.D.
RAPT Finalizes Reverse Split Plan; 1-for-8 Ratio Effective June 16, 2025 - Nasdaq
Friday, June 13, 2025 07:01 AM
Following the reverse split, RAPT's common stock will begin trading on a split-adjusted basis on the Nasdaq Global Market under the same ticker symbol 'RAPT,' starting June 17, 2025.
RAPT Therapeutics, Inc. Announces 1-for-8 Reverse Stock Split Effective June 16, 2025 - Nasdaq
Friday, June 13, 2025 06:12 AM
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on ...
RAPT historical stock data
date open high low close volume
30/06/25 8.46 8.46 7.966 8.00 71,200
27/06/25 9.74 9.84 8.24 8.43 593,000
26/06/25 9.59 9.76 8.83 9.73 119,300
25/06/25 8.24 9.59 8.00 9.56 168,600
24/06/25 7.50 8.22 7.355 8.22 87,900
23/06/25 7.44 7.79 7.04 7.44 107,400
20/06/25 7.50 7.50 7.09 7.43 152,900
18/06/25 7.35 7.79 6.88 7.42 105,554
17/06/25 8.13 8.9072 7.78 7.84 102,513
16/06/25 8.48 8.60 7.9016 8.24 900,891
Quote Details
52wk Low:5.664
52wk High:30.60
Vol:71.2K
Avg Vol(3m):15.6M
1Y Chng:-73.33%
1M Chng:+19.26%
Add to Watch List
More Information
Index US Composite
Market Cap. 139.40M